Notice: This company has been marked as potentially delisted and may not be actively trading. Augmedix (AUGX) Stock Forecast & Price Target Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipTrendsBuy This Stock Get the Latest News and Ratings for AUGX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Augmedix and its competitors. Enter your email to sign up for newsletter Sign Up AUGX Analyst Ratings Over TimeTypeCurrent Forecast3/29/24 to 3/29/251 Month Ago2/28/24 to 2/27/253 Months Ago12/30/23 to 12/29/241 Year Ago3/30/23 to 3/29/24Strong Buy0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)Buy0 Buy rating(s)0 Buy rating(s)0 Buy rating(s)1 Buy rating(s)Hold4 Hold rating(s)4 Hold rating(s)4 Hold rating(s)1 Hold rating(s)Sell0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)Consensus Price Target$3.09$3.09$3.09$4.75Forecasted Upside31.38% Upside31.38% Upside31.38% Upside16.14% UpsideConsensus RatingHoldHoldHoldModerate Buy Remove Ads AUGX Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History AUGX Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table Augmedix Stock vs. The CompetitionTypeAugmedixMedical CompaniesS&P 500Consensus Rating Score 2.00 2.82 2.54Consensus RatingHoldModerate BuyModerate BuyPredicted Upside31.38% Upside18,542.90% Upside19.88% UpsideNews Sentiment RatingNeutral NewsSee Recent AUGX NewsPositive NewsPositive News Remove Ads Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame Start Date End Date Most Recent from Each Brokerage All Show Export to Excel DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails7/22/2024Lake Street Capital1 of 5 starsB. O'neilSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Hold7/19/2024William Blair1 of 5 starsR. DanielsSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold7/19/2024B. Riley3 of 5 starsY. ZhiSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold$3.00 ➝ $2.35+3.98%5/14/2024Maxim GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingA. KleeSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Hold$5.00 ➝ $5.00+113.67%5/14/2024Evercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingE. AndersonSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeOutperform ➝ Inline$5.00 ➝ $1.50-35.90%Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 03:45 AM ET. AUGX Forecast - Frequently Asked Questions What is Augmedix's forecast for 2025? According to the research reports of 4 Wall Street equities research analysts, the average twelve-month stock price forecast for Augmedix is $3.09, with a high forecast of $5.00 and a low forecast of $1.50. Should I buy or sell Augmedix stock right now? 4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Augmedix in the last twelve months. There are currently 4 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" AUGX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AUGX, but not buy additional shares or sell existing shares. Does Augmedix's stock price have much upside? According to analysts, Augmedix's stock has a predicted upside of 31.38% based on their 12-month stock forecasts. Do Wall Street analysts like Augmedix more than its competitors? Analysts like Augmedix less than other "medical" companies. The consensus rating for Augmedix is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how AUGX compares to other companies. Stock Forecasts and Research Tools Related Companies OABI Stock Forecast ZH Stock Forecast BWMN Stock Forecast IMXI Stock Forecast OOMA Stock Forecast RMNI Stock Forecast ABSI Stock Forecast MXCT Stock Forecast IBEX Stock Forecast MPLN Stock Forecast Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter This page (NASDAQ:AUGX) was last updated on 3/29/2025 by MarketBeat.com Staff From Our PartnersA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Augmedix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Augmedix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AUGX Stock Free AUGX Stock Alerts